You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 8, 2025

Drug Price Trends for ETODOLAC ER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ETODOLAC ER

Average Pharmacy Cost for ETODOLAC ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ETODOLAC ER 400 MG TABLET 00093-1122-01 1.11789 EACH 2025-01-22
ETODOLAC ER 400 MG TABLET 16714-0497-01 1.11789 EACH 2025-01-22
ETODOLAC ER 400 MG TABLET 51672-4051-01 1.11789 EACH 2025-01-22
ETODOLAC ER 400 MG TABLET 16714-0497-02 1.11789 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Etodolac ER

Introduction to Etodolac ER

Etodolac ER, or etodolac extended-release, is a nonsteroidal anti-inflammatory drug (NSAID) widely used for the treatment of various musculoskeletal and inflammatory conditions, including osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis. Here’s a comprehensive analysis of the market and price projections for this medication.

Market Size and Growth

The etodolac market, including both immediate-release and extended-release formulations, has been experiencing steady growth. As of 2023, the etodolac market was valued at USD 450 million and is projected to reach USD 657.15 million by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5% from 2024 to 2031[1].

Key Drivers of Market Growth

Several factors are driving the growth of the etodolac market:

  • Increasing Incidence of Chronic Pain: The rising incidence of chronic pain conditions, such as osteoarthritis and rheumatoid arthritis, is a significant driver. Etodolac's effectiveness in reducing pain and inflammation makes it a preferred choice for these conditions[1].
  • Advancements in Formulations: Improvements in formulations, particularly the development of extended-release tablets, enhance therapeutic outcomes and patient compliance. These formulations provide sustained relief and are more convenient for patients[1][4].
  • Safety Profile: Etodolac has a favorable safety profile compared to other NSAIDs, making it more appealing to both patients and healthcare professionals[1].
  • Generic Availability: The availability of generic etodolac formulations reduces costs and increases accessibility, further boosting market growth[1][5].

Market Segmentation

The etodolac market is segmented based on application, product type, and geographical regions.

  • Application: Etodolac is available in various forms, including tablets, capsules, extended-release tablets, and oral suspension. Extended-release tablets are particularly popular due to their convenience and efficacy[1].
  • Product Type: The primary uses of etodolac include pain relief, anti-inflammatory treatment, osteoarthritis treatment, and rheumatoid arthritis treatment[1].
  • Geographical Regions: The market is analyzed across North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. Each region has its own market dynamics and growth prospects[1].

Price Analysis

The prices of etodolac ER vary based on the dosage, quantity, and pharmacy.

  • Extended-Release Tablets:
    • For a supply of 100 etodolac 400 mg extended-release tablets, the price can range from $52.70 to $251.70, depending on the pharmacy and availability[2].
    • For a supply of 100 etodolac 500 mg extended-release tablets, the price can range from $59.74 to $225.24[2].
    • For a supply of 60 etodolac 600 mg extended-release tablets, the price can be around $179.81[2].

Cost-Effectiveness Analysis

Studies have shown that etodolac is cost-effective compared to other NSAIDs. For instance, a study comparing etodolac with aceclofenac found that etodolac, despite being more expensive, provided better therapeutic effects and was more cost-effective in the long run[3].

Pharmacokinetics and Clinical Efficacy

Etodolac extended-release tablets have a high systemic availability, with peak concentrations occurring approximately 6 hours after dosing. Clinical trials have demonstrated that etodolac extended-release tablets provide efficacy comparable to immediate-release etodolac in managing the signs and symptoms of osteoarthritis and rheumatoid arthritis[4].

Patient Assistance and Discounts

To make etodolac more affordable, various patient assistance programs and discount cards are available. For example, the Drugs.com Discount Card can save patients up to 80% on prescription medications, including etodolac[2].

Future Market Trends

  • Increased Demand for Chronic Pain Management: The growing awareness of effective pain management techniques and the increasing incidence of chronic pain conditions are expected to drive the demand for etodolac ER.
  • Advancements in Drug Formulations: Continued improvements in drug formulations, such as more efficient extended-release systems, will enhance patient compliance and therapeutic outcomes.
  • Generic Market Expansion: The availability of generic etodolac formulations will continue to make the drug more accessible and affordable, contributing to market growth.

Key Takeaways

  • The etodolac market is expected to grow significantly, driven by the increasing incidence of chronic pain conditions and advancements in drug formulations.
  • Etodolac ER is particularly popular due to its convenience and efficacy.
  • The drug has a favorable safety profile and is cost-effective compared to other NSAIDs.
  • Patient assistance programs and discount cards can make etodolac more affordable.

FAQs

  1. What is the primary use of etodolac ER?

    • Etodolac ER is primarily used for the treatment of osteoarthritis, rheumatoid arthritis, and other musculoskeletal and inflammatory conditions.
  2. How does the price of etodolac ER compare to other NSAIDs?

    • The price of etodolac ER can vary, but it is generally competitive with other NSAIDs. However, its cost-effectiveness is often higher due to its better therapeutic outcomes[3].
  3. What are the benefits of extended-release etodolac tablets?

    • Extended-release etodolac tablets provide sustained relief, enhance patient compliance, and have a high systemic availability, making them more convenient and effective[4].
  4. Are there any patient assistance programs available for etodolac ER?

    • Yes, various patient assistance programs and discount cards, such as the Drugs.com Discount Card, can help make etodolac ER more affordable[2].
  5. What is the projected market size of etodolac by 2031?

    • The etodolac market is expected to reach USD 657.15 million by 2031, growing at a CAGR of 5% from 2024 to 2031[1].

Sources

  1. Market Research Intellect: Etodolac Market Size, Overview & Research Report [2024-2031]
  2. Drugs.com: Etodolac Prices, Coupons, Copay Cards & Patient Assistance
  3. ISPOR: Cost-Effectiveness Analysis of Etodolac and Aceclofenac
  4. DailyMed: Etodolac Extended-Release Tablets, 400 mg, 500 mg and 600 mg
  5. Drugs.com: Lodine Prices, Coupons, Copay Cards & Patient Assistance

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.